Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Caffeine test assessment for measuring liver function in critically ill patients

O Calatayud1, M Rodríguez, A Sánchez-Alcaraz

  • 1Department of Laboratory, Lluis Alcanyis Hospital, Xativa, Spain.

Journal of Clinical Pharmacy and Therapeutics
|February 1, 1995
PubMed
Summary

Caffeine elimination differs significantly in intensive care patients with liver disease. Slower caffeine clearance and longer half-life in liver disease patients indicate impaired liver function, useful for clinical assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of vigabatrin on the pharmacokinetics of carbamazepine.

Journal of clinical pharmacy and therapeutics·2002
Same author

Therapeutic drug monitoring of tobramycin: once-daily versus twice-daily dosage schedules.

Journal of clinical pharmacy and therapeutics·1999
Same author

Placental transfer and neonatal effects of propofol in caesarean section.

Journal of clinical pharmacy and therapeutics·1998
Same author

Valproic acid clearance in children with epilepsy.

Journal of clinical pharmacy and therapeutics·1998
Same author

[Pharmacokinetics of lidocaine in obstetric patients after its epidural single-dose administration].

Revista espanola de anestesiologia y reanimacion·1997
Same author

Plasma concentrations of vigabatrin in epileptic patients.

Journal of clinical pharmacy and therapeutics·1996

Area of Science:

  • Pharmacokinetics
  • Hepatology
  • Critical Care Medicine

Background:

  • Caffeine is a widely consumed substance.
  • Its elimination can be affected by liver function.
  • Assessing liver function in intensive care units (ICUs) is crucial.

Purpose of the Study:

  • To investigate caffeine elimination parameters in ICU patients.
  • To determine if liver disease impacts caffeine metabolism.
  • To evaluate the utility of caffeine biotransformation for assessing liver function.

Main Methods:

  • Studied caffeine elimination in 73 ICU patients.
  • Compared patients with and without liver disease (33 had liver disease).
  • Measured plasma clearance (Cl) and half-life (t1/2) of caffeine.

Related Experiment Videos

Main Results:

  • Significantly lower mean plasma clearance of caffeine in patients with liver disease (0.39 ml/kg/min) compared to those without (1.30 ml/kg/min).
  • Significantly longer mean half-life of caffeine in patients with liver disease (23.96 h) versus those without (7.25 h).
  • No significant differences in caffeine distribution volumes were observed between groups.

Conclusions:

  • Caffeine biotransformation parameters (clearance and half-life) are significantly altered in ICU patients with liver disease.
  • These parameters demonstrate high diagnostic value for assessing liver function in this population.
  • Caffeine elimination kinetics serve as a useful indicator of hepatic function in critically ill patients.